Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2292685rdf:typepubmed:Citationlld:pubmed
pubmed-article:2292685lifeskim:mentionsumls-concept:C0003308lld:lifeskim
pubmed-article:2292685lifeskim:mentionsumls-concept:C0036847lld:lifeskim
pubmed-article:2292685lifeskim:mentionsumls-concept:C0204727lld:lifeskim
pubmed-article:2292685lifeskim:mentionsumls-concept:C0205409lld:lifeskim
pubmed-article:2292685lifeskim:mentionsumls-concept:C0678594lld:lifeskim
pubmed-article:2292685lifeskim:mentionsumls-concept:C0644562lld:lifeskim
pubmed-article:2292685pubmed:issue5lld:pubmed
pubmed-article:2292685pubmed:dateCreated1991-4-10lld:pubmed
pubmed-article:2292685pubmed:abstractTextA new antifungal compound, CAF-603, was isolated from the culture broth of Gliocladium virens IFO 9166. The structure of compound 1 has been elucidated by spectroscopic methods that also allowed the relative stereochemistry to be assigned. CAF-603 [1] was active against yeasts and dermatophytes.lld:pubmed
pubmed-article:2292685pubmed:languageenglld:pubmed
pubmed-article:2292685pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2292685pubmed:citationSubsetIMlld:pubmed
pubmed-article:2292685pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2292685pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2292685pubmed:statusMEDLINElld:pubmed
pubmed-article:2292685pubmed:issn0163-3864lld:pubmed
pubmed-article:2292685pubmed:authorpubmed-author:OmuraSSlld:pubmed
pubmed-article:2292685pubmed:authorpubmed-author:MizutaniTTlld:pubmed
pubmed-article:2292685pubmed:authorpubmed-author:WatanabeNNlld:pubmed
pubmed-article:2292685pubmed:authorpubmed-author:YamagishiMMlld:pubmed
pubmed-article:2292685pubmed:authorpubmed-author:HanadaKKlld:pubmed
pubmed-article:2292685pubmed:authorpubmed-author:KondohHHlld:pubmed
pubmed-article:2292685pubmed:authorpubmed-author:KushidaKKlld:pubmed
pubmed-article:2292685pubmed:issnTypePrintlld:pubmed
pubmed-article:2292685pubmed:volume53lld:pubmed
pubmed-article:2292685pubmed:ownerNLMlld:pubmed
pubmed-article:2292685pubmed:authorsCompleteYlld:pubmed
pubmed-article:2292685pubmed:pagination1176-81lld:pubmed
pubmed-article:2292685pubmed:dateRevised2000-12-18lld:pubmed
pubmed-article:2292685pubmed:meshHeadingpubmed-meshheading:2292685-...lld:pubmed
pubmed-article:2292685pubmed:meshHeadingpubmed-meshheading:2292685-...lld:pubmed
pubmed-article:2292685pubmed:meshHeadingpubmed-meshheading:2292685-...lld:pubmed
pubmed-article:2292685pubmed:meshHeadingpubmed-meshheading:2292685-...lld:pubmed
pubmed-article:2292685pubmed:meshHeadingpubmed-meshheading:2292685-...lld:pubmed
pubmed-article:2292685pubmed:meshHeadingpubmed-meshheading:2292685-...lld:pubmed
pubmed-article:2292685pubmed:meshHeadingpubmed-meshheading:2292685-...lld:pubmed
pubmed-article:2292685pubmed:articleTitleCAF-603: a new antifungal carotane sesquiterpene. Isolation and structure elucidation.lld:pubmed
pubmed-article:2292685pubmed:affiliationResearch Institute, Taisho Pharmaceutical, Saitama-ken, Japan.lld:pubmed
pubmed-article:2292685pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2292685lld:pubmed